Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

NIU researchers offer improved vector delivery system for ribozymes

Nov. 8, 1996

Scherer-Merck softgel development agreement

Nov. 8, 1996

CellPro to begin clinical trial of T-cell depletion system

Nov. 1, 1996

Lynx signs two agreements with BASF

Nov. 1, 1996

Strategy and outlook for HemaSure's blood pathogen inactivation system

Nov. 1, 1996

Andrx drug delivery technology receives patent coverage

Nov. 1, 1996

Varian, Stanford University and SRI collaborative agreement aimed at new cancer cures

Nov. 1, 1996

3-Dimensional Pharmaceutical's DirectedDiversity technology for drug discovery

Nov. 1, 1996

Xenova, Warner-Lambert sign drug discovery collaborative agreement

Nov. 1, 1996

NIH seeks licensees for method of detecting cardiac electrical activity

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...